Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Fleshner

Showing results (211-220 of 260) with videos related to

Pageof 26
Sort By:
Pathology Oncology Research : POR|April 7, 2018
A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray CoresSami-Ramzi Leyh-Bannurah, Dominique Trudel, Mathieu Latour, et al.
Nature Nanotechnology|November 22, 2016
Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic rankingMahla Poudineh, Peter M Aldridge, Sharif Ahmed, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 7, 2018
Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectivesRashid K Sayyid, Abdallah K Sayyid, Zachary Klaassen, et al.
European Urology|May 6, 2026
Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled TrialsDavid-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, et al.
BJU International|February 1, 2011
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatmentDavid M Kakiashvili, Bas W G van Rhijn, Greg Trottier, et al.
Cancer Management and Research|December 6, 2019
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And OutcomeSierra Cheng, Vanessa Arciero, Hanan Goldberg, et al.
The Journal of Urology|June 24, 2026
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort StudyMarie-Pier St-Laurent, Shayan Din, Joseph Moryousef, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
European Urology|November 1, 2011
A new and highly prognostic system to discern T1 bladder cancer substageBas W G van Rhijn, Theo H van der Kwast, Sultan S Alkhateeb, et al.
BJU International|December 22, 2019
Salvage radical prostatectomy following focal therapy: functional and oncological outcomesJaime O Herrera-Caceres, Gregory J Nason, Noelia Salgado-Sanmamed, et al.
Pageof 26

Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Pathology Oncology Research : POR|April 7, 2018
A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray CoresSami-Ramzi Leyh-Bannurah, Dominique Trudel, Mathieu Latour, et al.
Nature Nanotechnology|November 22, 2016
Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic rankingMahla Poudineh, Peter M Aldridge, Sharif Ahmed, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 7, 2018
Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectivesRashid K Sayyid, Abdallah K Sayyid, Zachary Klaassen, et al.
European Urology|May 6, 2026
Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled TrialsDavid-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, et al.
BJU International|February 1, 2011
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatmentDavid M Kakiashvili, Bas W G van Rhijn, Greg Trottier, et al.
Cancer Management and Research|December 6, 2019
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And OutcomeSierra Cheng, Vanessa Arciero, Hanan Goldberg, et al.
The Journal of Urology|June 24, 2026
Oncological Outcomes of Non-Muscle Invasive Bladder Cancer in Patients Aged ≤45: A Retrospective Matched Cohort StudyMarie-Pier St-Laurent, Shayan Din, Joseph Moryousef, et al.
BMJ Open|April 25, 2020
[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trialRachel M Glicksman, Ur Metser, John Valliant, et al.
European Urology|November 1, 2011
A new and highly prognostic system to discern T1 bladder cancer substageBas W G van Rhijn, Theo H van der Kwast, Sultan S Alkhateeb, et al.
BJU International|December 22, 2019
Salvage radical prostatectomy following focal therapy: functional and oncological outcomesJaime O Herrera-Caceres, Gregory J Nason, Noelia Salgado-Sanmamed, et al.
Pageof 26